INM
InMedFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
INM vs peer average
48/100
INM vs. peer average (F vs. F)
Grade spread
D 1 · F 6
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
RNAZ is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $5.02M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
INM
InMed
RNAZ
TransCode Therapeutics
Grade
F
F
Momentum
12
8
Value
58
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs RNAZ
INM / RNAZ
Grade Position
In line
INM vs. peer average (F vs. F)
48/100
Momentum
12
INMValue
58
INMSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs INM
RNAZ is the first peer returned for this comparison set.

